Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Exscientia
Biotech
Recursion lays off 20% of staff in wake of pipeline cutbacks
Recursion Pharmaceuticals is laying off a fifth of its workforce in connection with a previously announced streamlining of the AI biotech’s pipeline.
James Waldron
Jun 10, 2025 9:25am
Recursion streamlines pipeline following merger with Exscientia
May 5, 2025 11:00am
After a tough year, Exscientia folds into Recursion
Aug 8, 2024 8:54am
Exscientia pays $20M for full control of CDK7 cancer prospect
Jul 18, 2024 10:08am
Sanofi, Lilly, Amarin & more—Chutes & Ladders
Jun 7, 2024 8:30am
Exscientia cuts a quarter of staff while preserving AI pipeline
May 21, 2024 11:17am